Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells

Blood

Volumn 87, Issue 8, 1996, Pages 3245-3254

  Laurence, Jeffrey ^a   Mitra, Debashis ^a   Steiner, Melissa ^a   Staiano Coico, Lisa ^a   Jaffe, Eric ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ETIOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MICROVASCULATURE; PRIORITY JOURNAL;

ACRIDINE ORANGE; ANTIGENS, CD36; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CAPILLARIES; CHROMATIN; DNA DAMAGE; ELECTROPHORESIS, AGAR GEL; ENDOTHELIUM, VASCULAR; FAS LIGAND PROTEIN; FLUORESCENT DYES; HIV INFECTIONS; HUMANS; INDOLES; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEPHELOMETRY AND TURBIDIMETRY; ORGAN SPECIFICITY; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SKIN; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0029868454     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.8.3245.bloodjournal8783245     Document Type: Article

References (55)

1. Kwaan HC: Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 24:71, 1987
2. Ucar A, Fernandez HF, Byrnes JJ, Lian EC-Y, Harrington WJ Jr: Thrombotic microangiopathy and retrovjral infections: A 13-year experience. Am J Hematol 45:304, 1994
3. Rarick MU, Espina B, Mocharnuk R, Trilling Y, Levine AM: Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: A report of three cases and review of the literature. Am J Hematol 40:103, 1992
4. Thompson C, Daman LE, Ries CA, Linker CA: Thrombotic microangiopathies in the 1980's: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80:1890, 1992
5. Leaf AN, Laubenstein LJ, Raphael B, Hockster H, Baez L, Karpatkin J: Thrombotic thrombocytopenic purpura associated with HIV-1 infection. Ann Intern Med 109:194, 1988
6. Moake JL: Hemolytic-uremic syndrome: Basic science. Lancet 343:393, 1994
7. Massio C, Peraldi MN, Desenclos JC, Sraer JD, Rozenbaum W: Evidence for the role of cytomegalovirus in thrombotic microangiopathy (TMA) in HIV-infected patients. Second National Conference on Human Retroviruses, Washington, DC, January 31 to Feb 3, 1995 (abst LB22)
8. Lian E C-Y: Pathogenesis of thrombotic thrombocytopenic purpura. Semin Hematol 24:82, 1989
9. Moake J, Chintagumpala M, Turner N, McPherson P, Nolasco L, Steuber C, Stantiago-Borrero P, Horowitz M, Pehta J: Solvent/ detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenia purpura. Blood 84.490, 1994
10. Burns ER, Zucker-Franklin D: Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood 60:1030, 1982
11. Leung DYM, Moake JL, Havens PL, Kim JM, Pober JS: Lytic anti-endothelial cell antibodies are present in hemolytic uremic syndrome. Lancet 1:183, 1988
12. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745, 1973
13. Savill J, Hogg N, Ren Y, Haslett C: Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90:1513, 1992
14. Laurence J, Cooke H, Sikder SK: Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1. Blood 75:696, 1990
15. Darzynkiewicz Z, Bruno S, DelBino G, Gorczyca W, Hotzma A, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
16. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S: Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type 1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392, 1993
17. Terai C, Kornbluth RS, Pauda CD, Richman DD, Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710, 1991
18. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonchora M, Yonchara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620, 1990
19. Takizawa T, Fukuda R, Miyawaki T, Ohashi K, Nakanishi Y: Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. Virology 209:288, 1995
20. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
21. Itoh N, Yonehara S, Ishii A, Yonchara M, Mizushima SF, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
22. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas-ligand: Gene structure, chromosomal location and species specificity. Int Immunol 6:1567, 1994
23. Laurence J, Hodtsev AS, Posnett DN: Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vβ expression. Nature 358:255, 1992
24. Alderson MR, Tough TW, Braddy S: Regulation of apoptosis and T cell activation by Fas-specific mAb. Int Immunol 6:1799, 1994
25. Stewart BW: Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 86:1286, 1994
26. Kawasaki T, Kaku S, Kohinata T, Sukai Y, Taniuchi Y, Kawamura K, Yano S, Takemaka T, Fujimura S: Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GP1b, platelet retention, and thrombus formation in vivo. Am J Hematol 47:6, 1994
27. Byrnes JJ, Moake JL, Klug P, Periman S: Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 34:169, 1990
28. + T cell in vitro and in vivo: Association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology (in press)
29. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH, Moller P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/TNF receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415, 1993
30. Robaye B, Masselmans R, Fiers W, Dumont JE, Galand P: Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothehal cells in vitro. Am J Pathol 138:447, 1991
31. Cavendar DE, Edelbaum D, Ziff M: Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol 134:551, 1989
32. Cushman M, Sherman P: Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem Biophys Res Commun 172:1298, 1990
33. McConkey DJ, Hartzell P, Nicotera P, Orrenius S: Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J 3:1843, 1989
34. 2+ concentration and DNA fragmentation. Cancer Res 52:1342, 1992
35. Favaloro EJ, Moraitis N, Bradstock K, Koutts J: Co-expression of haemopoietic antigens on vascular endothelial cells: A detailed phenotypic analysis. Br J Haematol 74:385, 1990
36. Petzelbauer P, Bender JR, Wilson J, Pober JS: Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 151:5062, 1993
37. Swerlick RA, Lee KH, Wick TM, Lawley TJ: Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 148:78, 1992
38. Tandon NN, Rock G, Jamieson GA: Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. Br J Haematol 88:816, 1994
39. Trezzini C, Jungi TW, Spycher MO, Maly FE, Rao P: Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction. Immunology 71:29, 1990
40. Takahashi H, Hanano M, Wada K, Takewaki W, Niwano H, Tsubouchi J, Nakano M, Nakamura T, Shibata A: Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol 38:174, 1991
41. Remuzzi G, Zoja C, Rossi EC: Prostacyclin in thrombotic microangiopathy. Semin Hematol 24:110, 1987
42. Neame PB: Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP). Semin Thromb Hemostasis 6:416, 1980
43. Koenig DW, Barley-Maloney L, Daniel TO: A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies. J Clin Immunol 13:204, 1993
44. Madri JA, Bell L, Marx M, Merwin JR, Basson C, Prinz C: Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de-endothelialization and repair. J Cell Biochem 45:123, 1991
45. Bryson GJ, Harmon BV, Collins RJ: A flow cytometric study of cell death: failure of some models to correlate with morphological assessment. Immunol Cell Biol 72:35, 1994
46. Wallace DC, Lovric A, Clubb JS, Carseldine DB: Thrombotic thrombocytopenic purpura in four siblings. Am J Med 58:724, 1975
47. Lefevre P, George F, Durand JM, Sampol J: Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura. Thromb Haemost 69:522, 1993
48. Nalbandian RM, Henry RL, Bick RL: Thrombotic thrombooytopenic purpura: An extended editorial. Semin Thromb Hemost 5:216, 1979
49. Kelton JG, Warkentin TE, Hayward CPM, Murphy WG, Moore JC: Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood 80:2246, 1992
50. Sarin A, Adams DH, Henkart PA: Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J Exp Med 178:1693, 1993
51. Han DKM, Haudenschild CC, Kong MK, Tinkle BT, Leon MB, Liau G: Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 147:267, 1995
52. Shumak KH, Rock GA, Nair RC: Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med 122:569, 1995
53. del Arco A, Martinez MA, Pena JM, Gamallo C, Gonzalez JJ, Barbado FJ, Vazquez JJ: Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: Demonstration of p24 antigen in endothelial cells. Clin Infect Dis 17:360, 1993
54. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456, 1995
55. Torok TJ, Holman RC, Chorba TL: Increasing mortality from thrombotic thrombocytopenic purpura in the United States - Analysis of national mortality data, 1968-1991. Am J Hematol 50:84, 1995